Vienna
Austria
59
2022-10-27
The entities that hold a legal rights for patent applications filed by inventor Solca Flavio:
Flavio Solca from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:
ANTI CANCER COMBINATION THERAPY
#2 | 2019-05-02ANTICANCER COMBINATION THERAPY
#3 | 2018-12-20QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
#4 | 2018-12-06Anti-cancer combination therapy
#5 | 2018-03-29COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
#6 | 2017-11-02METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
#7 | 2017-04-27QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
#8 | 2017-03-30ANTICANCER COMBINATION THERAPY
#9 | 2016-04-14METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
#10 | 2015-10-01Quinazoline derivatives for the treatment of cancer diseases
#11 | 2015-09-24COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#12 | 2014-11-20METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
#13 | 2014-07-17COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
#14 | 2014-07-10ANTICANCER THERAPY
#15 | 2014-02-27COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#16 | 2013-10-31Combination therapy in treatment of oncological and fibrotic diseases
#17 | 2013-10-242,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS
#18 | 2013-07-11Quinazoline derivatives for the treatment of cancer diseases
#19 | 2013-01-10BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
#20 | 2013-01-03ANTICANCER THERAPY
#21 | 2012-12-27Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
#22 | 2012-11-22Method for EGFR directed combination treatment of non-small cell lung cancer
#23 | 2012-06-21METHOD FOR TREATING COLORECTAL CANCER
#24 | 2012-05-03Combination therapy in treatment of oncological and fibrotic diseases
#25 | 2011-10-132,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS
#26 | 2011-06-09COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#27 | 2011-04-14Pyrimidines as PLK inhibitors
#28 | 2011-03-31Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same
#29 | 2011-02-24METHODS OF TREATING DISEASES USING QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#30 | 2011-02-17COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#31 | 2010-12-23Dihydropteridinone compounds
#32 | 2010-09-02Substituted indolines as tyrosine kinase inhibitors
#33 | 2010-06-10Compounds
#34 | 2010-03-18BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM
#35 | 2010-01-14Quinazoline derivatives and pharmaceutical compositions containing them
#36 | 2009-12-24Method for treating cancer harboring EGFR mutations
#37 | 2009-12-10Quinazoline derivatives for the treatment of cancer diseases
#38 | 2009-08-13BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE, AND PROCESSES FOR PREPARING THEM
#39 | 2009-06-25Compounds
#40 | 2009-06-25Pyrimidines as PLK inhibitors
#41 | 2009-06-11Pyrimidines as PLK inhibitors
#42 | 2009-05-142-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments
#43 | 2008-10-16Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
#44 | 2008-07-17Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same
#45 | 2008-05-01Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
#46 | 2007-09-062,4-diaminopyrimidines useful for treating cell proliferation diseases
#47 | 2007-05-22Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
#48 | 2007-02-082,4-diamino-pyrimidines as aurora inhibitors
#49 | 2006-07-06Pyrimidines as PLK inhibitors
#50 | 2006-03-28Quinazoline derivatives and pharmaceutical compositions containing them
#51 | 2006-03-09Dihydropteridione derivatives, process for their manufacture and their use as medicament
#52 | 2006-03-02Dihydropteridione derivatives, process for their manufacture and their use as medicament
#53 | 2006-02-02Methods for treating diseases or conditions using dihydropteridinone compounds
#54 | 2006-01-196-formyl-tetrahydropteridines, process for their manufacture and use thereof as medicaments
#55 | 2005-12-064-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
#56 | 2005-08-18Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
#57 | 2005-08-02Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
#58 | 2005-05-19Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
#59 | 2005-03-01Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
10572 ⎘